Nobu Deep throat
Natural health product licensed in Canada
- Licence holder
- Kaytel Media Group Inc.
- NPN or DIN-HM
- 80084022
- Status
- Inactive licence
- Licence date
- 26 March 2018
- Revision date
- Not provided
- Form
- Vaporisateur
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide 4-aminobenzoïque, Ester d'éthyle Source : Acide para-aminobenzoïque | 7 % | Not calculated |
Non-medicinal ingredients
Glycérine, Aqua, Saveur, Ethanol, Sucrose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | 1 Pulvérisateur | minimum: 1 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
For the temporary relief of occasional minor oral irritation/oral pain/sore mouth and sore throat. For the temporary relief of pain associated with canker sores/aphthous stomatitis and cold sores/fever blisters/oral herpes. For the temporary relief of occasional minor irritation or injury of the mouth. For the temporary relief of pain due to minor irritation of the mouth due to dentures or orthodontic appliances.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
If symptoms do not improve within seven days, irritation, pain or redness persists or worsens, or swelling, rash or fever develops, consult your dentist or other health care practitioner promptly.
- Effets indésirables connus
Hypersensitivity/allergy is known to occur. In such a case, discontinue use.
- Contre-indications
If the following symptoms appear: weakness, confusion, headache, difficulty breathing and/or pale, gray or blue coloured skin, stop use and consult a health care practitioner. These symptoms may be signs of methemoglobinemia, a rare disorder, which may appear up to 2 hours after use. If allergic to benzocaine, do not use this product. If sore throat is severe, persists for more than two days, or is accompanied by or followed by other symptoms such as fever, headache, rash, swelling, nausea, or vomiting, consult a health care practitioner promptly.
Source
Official Health Canada record, licence 80084022
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.